Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 5—October 2001
Synopsis

Cost-Effectiveness of a Potential Vaccine for Coccidioides immitis

Amber E. Barnato*Comments to Author , Gillian D. Sanders†, and Douglas K. Owens†‡
Author affiliations: *University of Pittsburgh, Pittsburgh, Pennsylvania, USA; †Stanford University, Stanford, California, USA; ‡VA Palo Alto Health Care System, Palo Alto, California, USA

Main Article

Table 1

Lifetime cases of dissemination, disability, and death prevented and costs per 100,000 population if children are vaccinated and adults are screened, then vaccinated

 Dissemination prevented
 Disability prevented
 Deaths prevented
 Net cost ($ millions)
Compliance Children Adults Children Adults Children Adults Children Adults
100% 154 63 106 39 12 4 -3.3 9
80% 124 50 85 32 10 3 -2.6 7.2
60% 93 38 64 24 7 2 -2 5.4
40% 62 25 42 16 5 2 -1.3 3.6

Main Article

Page created: April 26, 2012
Page updated: April 26, 2012
Page reviewed: April 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external